Active, not recruitingPhase 1NCT06546709
DMID 23-0015; Lassa Fever CVD 1000
Studying Lassa fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wilbur Chen, MD, MS
- Intervention
- LASSARAB+ aPHAD-SEat 700rU(biological)
- Enrollment
- 55 enrolled
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06546709 on ClinicalTrials.govOther trials for Lassa fever
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07419373ARN-75039 Lassa Fever Treatment in West AfricaArisan Therapeutics, Inc.
- RECRUITINGPHASE2, PHASE3NCT06212336ISTH/ANRS 0409s INTEGRATE Lassa Fever StudyIrrua Specialist Teaching Hospital
- RECRUITINGPHASE2NCT05868733A Lassa Fever Vaccine Trial in Adults and Children Residing in West AfricaInternational AIDS Vaccine Initiative
- RECRUITINGPHASE2NCT06222723LAssa Fever Adjunct Treatment With DEXamethasoneBernhard Nocht Institute for Tropical Medicine
- ACTIVE NOT RECRUITINGNCT03655561Lassa Fever Clinical Course and Prognostic Factors in NigeriaAlliance for International Medical Action